Ultragenyx Pharmaceutical (RARE) FCF Payout Ratio (2014)

Ultragenyx Pharmaceutical (RARE) reported FCF Payout Ratio of 0.39 for Q1 2014.

Ultragenyx Pharmaceutical (RARE) FCF Payout Ratio (2014) Analysis & Trends

Ultragenyx Pharmaceutical (RARE) has 1 years of FCF Payout Ratio data on file, last reported at 0.39 in Q1 2014.

FCF Payout Ratio for Q1 2014 came in at 0.39, changed N/A year-over-year; the trailing twelve-month figure through Dec 2014 was 0.1 (changed N/A YoY), and the FY2014 annual result was 0.1, changed N/A from the prior year.
FCF Payout Ratio was little changed at 0.39 in Q1 2014 per RARE's latest filing.
Over five years, FCF Payout Ratio peaked at 0.39 in Q1 2014 and troughed at 0.39 in Q1 2014.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	FCF Cover (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	-
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	-
9	Abivax	91.96 Bn	91.96 Bn	-	-
10	Ultragenyx Pharmaceutical	2.77 Bn	2.36 Bn	106.00 Mn	-

Historic Data

Download Data

Date	Value
Mar 31, 2014	-0.39